Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Sep 26;56(1):2402942. doi: 10.1080/07853890.2024.2402942

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.

PMC Copyright notice

Figure 4. — The data present the changes in AMH, CA125, estrogen, and hemoglobin concentration levels during the dienogest treatment. Throughout the 12-month dienogest treatment, there is no change in AMH levels (a, n = 36). A gradual decline is observed in CA125 levels (b, n = 46). Estrogen levels significantly decreased in the first 6 months and then stabilized (c, n = 39). An increase in hemoglobin concentration is noted, indicating a correction of anemia (d, n = 34). The statistical significance is marked as ns for no significance, * indicates p < .05, ** presents p < .01, and *** demonstrates p < .001.